A-40174

A-40174
Identifiers
	IUPAC name 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-prop-2-ynyl-3,4-dihydro-1H-chromeno[4,3-c]pyridin-10-ol;
CAS Number	26685-57-4 ;
PubChem CID	99040;
ChemSpider	89464 ;
UNII	5HF6EE0TC4;
ChEMBL	ChEMBL66108 ;
CompTox Dashboard (EPA)	DTXSID00949501 ;
Chemical and physical data
Formula	C26H37NO2
Molar mass	395.587 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c2c(C(C)(C)CCCCCC)cc(O)c1c2OC(C)(C)C(CC3)=C1CN3CC#C;
	InChI InChI=1S/C26H37NO2/c1-7-9-10-11-18(3)19(4)20-15-23(28)25-21-17-27(13-8-2)14-12-22(21)26(5,6)29-24(25)16-20/h2,15-16,18-19,28H,7,9-14,17H2,1,3-6H3 ; Key:PNEYWTKVWJBOMD-UHFFFAOYSA-N ;
	(what is this?) (verify)

A-40174 (SP-1) is an analgesic drug which acts as a potent cannabinoid receptor agonist, and was developed by Abbott Laboratories in the 1970s.^[1] It is a structural analog of dronabinol and dimethylheptylpyran.

References

^ Razdan RK (2009). "Structure–Activity Relationships of Classical Cannabinoids". In Reggio PR (ed.). The Cannabinoid Receptors. The Receptors. pp. 3–19. doi:10.1007/978-1-59745-503-9_1. ISBN 978-1-58829-712-9.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.